Home > IP News
In an unusual move, Pfizer has written to physician groups in the U.K. to warn that prescribing generic versions of its Lyrica medicine – specifically, for treating pain – would violate its patent. But the missive has concerned the largest group of U.K. doctors, underscoring the tension that drug makers sometimes encounter when efforts to enforce patent rights bumps up against patient access.
Jan 13, 2015
To continue reading, click here.
(These latest Intellectual Property (IP) news and events presented here, are prepared and compiled by us, the World Patent & Trademark Law Office (WPTO),for your reference and information)